Cargando…
Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
INTRODUCTION: Renin−angiotensin system (RAS) blockade using angiotensin-converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) is first-line therapy for IgA nephropathy (IgAN). There is a paucity of information on the predictors and magnitude of response to this treatment. METHODS: In...
Autores principales: | Bagchi, Soumita, Mani, Kalaivani, Swamy, Anitha, Barwad, Adarsh, Singh, Geetika, Bhowmik, Dipankar, Agarwal, Sanjay Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207308/ https://www.ncbi.nlm.nih.gov/pubmed/34169207 http://dx.doi.org/10.1016/j.ekir.2021.02.018 |
Ejemplares similares
-
Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study
por: Bagchi, Soumita, et al.
Publicado: (2019) -
Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022) -
The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients
por: Bagchi, Soumita, et al.
Publicado: (2022) -
Association of vitamin D status with disease severity and outcome in Indian patients with IgA nephropathy
por: Farooqui, Naba, et al.
Publicado: (2023) -
Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020)